Daniel Lewis Heilpern-Mallory

6PUBLICATIONS
43CO-AUTHORS
Biomedical instrumentationMedical infection agents (incl. prions)Medical biotechnology diagnostics (incl. biosensors)Molecular targetsMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 28, 2026
Pharmacological targeting of IRF4 as a therapeutic strategy for multiple myeloma.

|Apr 27, 2026
Myeloma Precursors Erode Durable Immunity: Results of the IMPACT study.

|Aug 08, 2025
SWIFT-seq enables comprehensive single-cell transcriptomic profiling of circulating tumor cells in multiple myeloma and its precursors.

Elizabeth D Lightbody, Romanos Sklavenitis-Pistofidis, Ting Wu

|Mar 12, 2025
Large-scale dependency and drug screens to characterize the therapeutic vulnerabilities of multiple myeloma with 1q.

Romanos Sklavenitis-Pistofidis, Elizabeth D Lightbody, Mairead Reidy

|Feb 10, 2025
Single-cell RNA sequencing defines distinct disease subtypes and reveals hypo-responsiveness to interferon in asymptomatic Waldenstrom's Macroglobulinemia.

Romanos Sklavenitis-Pistofidis, Yoshinobu Konishi, Daniel Heilpern-Mallory

|Sep 23, 2024
Selective Enhancer Gain-of-Function Deregulates MYC Expression in Multiple Myeloma.

Mahshid Rahmat, Kendell Clement, Jean-Baptiste Alberge

Pageof 1

Frequent Collaborators

6 joint publications

Irene M Ghobrial

4 joint publications

Michelle P Aranha

4 joint publications

Gad Getz

3 joint publications

Jean-Baptiste Alberge